Crigler-Najjar syndrome type 1 is a rare inherited condition that starts at birth and causes very high bilirubin levels in the blood. Babies with Crigler-Najjar syndrome type 1 usually develop severe jaundice early, and the early symptoms of Crigler-Najjar syndrome type 1 can include poor feeding, sleepiness, or signs of brain injury if bilirubin builds up. It may help to know that doctors have studied this condition for decades, and Crigler-Najjar syndrome type 1 is lifelong because the liver cannot process bilirubin normally. Without treatment, Crigler-Najjar syndrome type 1 can be life-threatening in infancy or childhood, although the exact outlook can vary with care. Treatment for Crigler-Najjar syndrome type 1 often includes daily phototherapy and close monitoring, and many children are considered for a liver transplant.
How many people live with Crigler-najjar syndrome type 1?
There is no single direct headcount for Crigler-Najjar syndrome type 1, but Orphanet classifies it as affecting fewer than 1 in 1,000,000 people, which works out to fewer than about 8,000 people worldwide (Orphanet, 2024; United Nations, 2024) and fewer than about 340 people in the United States (Orphanet, 2024; U.S. Census Bureau, 2024). Because this is based on a very rare-disease prevalence estimate rather than a direct count, the true numbers may be lower.
Overview
Crigler-najjar syndrome type 1Symptoms
Crigler-Najjar syndrome type 1 causes severe jaundice from birth, so the skin and whites of the eyes look very yellow. Without treatment, high bilirubin can harm the brain, leading to poor feeding, unusual movements, hearing loss, or developmental delay.
Outlook and prognosis
Crigler-Najjar syndrome type 1 needs lifelong, intensive care. Without very regular phototherapy and often a liver transplant, bilirubin can build up and seriously injure the brain, but early expert treatment can improve survival and day-to-day stability.
Causes and risk factors
Crigler-Najjar syndrome type 1 is caused by harmful changes in both copies of the UGT1A1 gene, usually inherited from each parent. Family history raises risk, while illness, fasting, and dehydration can worsen bilirubin buildup and symptoms.
Genetic influences
Genetics are central to Crigler-Najjar syndrome type 1. It is caused by harmful changes in the UGT1A1 gene, and the exact genetic variant can help confirm the diagnosis and guide family testing.
Diagnosis
Crigler-Najjar syndrome type 1 is usually suspected from very high bilirubin levels soon after birth and the pattern of severe, persistent jaundice. The genetic diagnosis of Crigler-Najjar syndrome type 1 is confirmed with genetic tests, alongside blood test results and clinical features.
Treatment and drugs
Crigler-Najjar syndrome type 1 is treated with daily intensive phototherapy, often for many hours, to lower bilirubin. Many living with Crigler-Najjar syndrome type 1 also need close specialist care, and a liver transplant can provide long-term control.
Symptoms
Crigler-Najjar syndrome type 1 often first affects everyday newborn routines: a baby may look deeply yellow, sleep through feeds, or be hard to wake for nursing or a bottle. The early features of Crigler-Najjar syndrome type 1 are caused by a very high level of bilirubin, a yellow pigment in the blood. Signs can vary from child to child and can change over time, but severe jaundice from the first days of life is the main feature, and any changes in alertness, feeding, or movement need urgent medical care.
Yellowing of the skin and whites of the eyes usually starts within the first few days after birth and is much stronger than typical newborn jaundice. In Crigler-Najjar syndrome type 1, this yellowing tends to persist rather than fade on its own.
Many babies are hard to wake for feeds, suck weakly, or tire quickly while nursing or bottle-feeding. This can make everyday routines stressful and may lead to poor weight gain if bilirubin levels stay very high.
Some babies seem unusually sleepy, less alert, or less responsive than expected between feeds. Loved ones often notice the changes first, especially when a baby is difficult to rouse or seems less engaged.
Very high bilirubin can affect the brain and cause arching of the back, stiffness, floppiness, unusual eye movements, or jerking spells. These are warning signs that need urgent medical attention.
How people usually first notice Crigler-najjar syndrome type 1?
How Crigler-Najjar syndrome type 1 is first noticed usually begins in the first days of life, when a newborn develops intense jaundice that does not fade as expected and may spread from the face to the chest, belly, arms, and legs. The first signs of Crigler-Najjar syndrome type 1 are very high bilirubin levels, a yellow pigment that builds up in the blood because the body cannot process it properly, often with poor feeding, unusual sleepiness, or low energy that makes doctors look more closely. For many families, the condition is first recognized in the newborn period during hospital checks, blood tests, or follow-up visits when the jaundice is much stronger or lasts much longer than typical newborn jaundice.
Types of Crigler-najjar syndrome type 1
No distinct types of Crigler-Najjar syndrome type 1 are widely recognized.
Can I slow down the onset of symptoms?
No. Crigler-Najjar syndrome type 1 is present from birth, so there is no proven lifestyle change that can meaningfully delay when symptoms begin. Research has not shown that diet, exercise, sleep, or supplements can prevent it, although careful medical care from the newborn period can lower the level of the yellow pigment building up in the blood and reduce the risk of serious brain injury. Well-established care includes urgent treatment with special light therapy and close specialist follow-up, and many living with this condition are eventually considered for a liver transplant; this cannot stop the condition from starting, but it can help protect health.
What genetics can tell you about symptoms
Genetics can explain a lot about symptoms in Crigler-Najjar syndrome type 1 because the condition is caused by changes in a gene that the liver needs to clear bilirubin, a yellow pigment made when red blood cells break down. In type 1, these gene changes usually shut this process down almost completely, so symptoms often begin in the newborn period and can be severe, with very high bilirubin levels and a high risk of brain injury if treatment is delayed. Genetics can confirm the diagnosis, but in this type the symptoms are usually severe across affected babies, so gene results are often more helpful for diagnosis and family planning than for predicting a wide range of day-to-day symptom differences.
Causes and risk factors
In Crigler-Najjar syndrome type 1, babies are born with changes in both copies of the UGT1A1 gene, so bilirubin builds up from the first days of life. This usually happens when each parent carries one changed copy and does not know it. The main risk is a family history of Crigler-Najjar syndrome type 1, and the chance is higher when parents are closely related or come from a family with known carriers. Illness, dehydration, fasting, and some medicines can push bilirubin levels even higher, but they do not cause the syndrome. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Crigler-Najjar syndrome type 1 is almost always caused by an inherited change in a gene called UGT1A1, which normally helps the liver clear bilirubin, the yellow substance made when red blood cells break down. It happens when a child inherits a nonworking copy of this gene from both parents, so the biggest risk factors are a family history of the condition or parents who are healthy carriers; the chance can also be higher when the parents are related by blood. There are no well-known lifestyle or pregnancy-related causes.
Environmental and biological risk factors
When families look into risk factors for Crigler-Najjar syndrome type 1, it helps to know that this is not a condition linked to the usual pregnancy or environmental exposures seen with some birth differences. Doctors often group risks into internal (biological) and external (environmental). For Crigler-Najjar syndrome type 1, well-established non-genetic risk factors have not been identified.
No outside exposure has been proven to cause Crigler-Najjar syndrome type 1 during pregnancy. That includes common household chemicals, air pollution, infections, or everyday stress based on current evidence.
Maternal illnesses such as diabetes or high blood pressure are not recognized independent causes of Crigler-Najjar syndrome type 1. Unlike some congenital conditions, this syndrome is not known to arise from a mix of pregnancy health factors.
Prematurity, low birth weight, and delivery complications do not make this syndrome occur. These issues can affect a newborn's overall early health, but they are not established risk factors for the condition itself.
Advanced maternal or paternal age has not been established as a risk factor for Crigler-Najjar syndrome type 1. This sets it apart from some chromosome conditions where age-related risk is clearer.
Genetic risk factors
For families dealing with severe newborn jaundice, Crigler-Najjar syndrome type 1 is usually traced to an inherited problem in a single bilirubin-processing gene. When people ask about the genetic causes of Crigler-Najjar syndrome type 1, the answer is most often disease-causing changes in UGT1A1, a gene that helps the liver clear bilirubin. The condition follows an autosomal recessive pattern, so it usually happens when a child inherits one nonworking copy from each parent. Some risk factors are inherited through our genes.
UGT1A1 changes: Crigler-Najjar syndrome type 1 happens when both copies of the UGT1A1 gene have harmful changes. In type 1, these changes stop the bilirubin-clearing protein from working, so bilirubin builds up in the body.
Recessive inheritance: This condition usually appears only when a child inherits two altered copies of the gene, one from each parent. Parents with one altered copy are usually healthy carriers and often do not know they carry it.
Carrier parents: If both parents carry a UGT1A1 change, each pregnancy has a 1 in 4, or 25%, chance of Crigler-Najjar syndrome type 1. There is also a 1 in 2, or 50%, chance that the child will be a carrier.
Family history: Having a sibling or close relative with this syndrome raises the chance that the same gene change runs in the family. This can be especially relevant when a family’s exact UGT1A1 variant is already known.
Related parents: The risk is higher when parents are blood relatives, such as cousins, because they are more likely to carry the same rare gene change. This does not cause the syndrome by itself, but it increases the chance that a child inherits two altered copies.
Founder variants: In some families or communities, the same rare UGT1A1 change has been passed down through generations. That can make carrier status more common in that group, even though the condition is still very rare overall.
Lifestyle risk factors
Crigler-Najjar syndrome type 1 is an inherited disorder, so lifestyle habits do not cause it. However, how lifestyle affects Crigler-Najjar syndrome type 1 can be important because daily habits may change bilirubin levels, trigger neurologic risk, or influence how well treatment works. The main concerns are avoiding situations that raise unconjugated bilirubin and supporting consistent phototherapy, nutrition, and overall stability.
Fasting or long gaps between meals can increase bilirubin levels in people with Crigler-Najjar syndrome type 1. Regular feeding, especially in infants and children, helps reduce catabolic stress that can worsen jaundice and raise the risk of bilirubin encephalopathy.
Vomiting, diarrhea, fever, or poor intake can lead to dehydration and metabolic stress that push bilirubin higher. Prompt hydration and early medical attention during intercurrent illness can help limit sudden worsening.
Overnight phototherapy is a core treatment, so irregular sleep patterns or poor adherence can reduce the time bilirubin is being lowered. A stable bedtime routine may improve treatment consistency and help keep bilirubin levels safer.
Alcohol does not cause the syndrome, but it can impair liver handling of bilirubin-related processes and worsen dehydration or missed treatment routines. Avoiding alcohol is especially important in adolescents and adults with this condition.
Risk prevention
Crigler-Najjar syndrome type 1 is a rare inherited condition, so the condition itself cannot usually be prevented. In daily life, prevention focuses on lowering the risk of very high bilirubin levels and protecting the brain from bilirubin injury, especially in babies and young children. Prevention is flexible—it adapts to your life and health background. For many living with Crigler-Najjar syndrome type 1, this means steady treatment, quick action during illness, and close follow-up with a specialist team.
Regular phototherapy is a main way to help prevent bilirubin from building up to dangerous levels in Crigler-Najjar syndrome type 1. Missing sessions can raise the risk of brain injury, even when a child seems well at first.
Frequent blood tests and specialist visits help track bilirubin levels and adjust treatment as a child grows. Prevention works best when combined with regular check-ups.
Fever, vomiting, dehydration, or poor feeding can make bilirubin rise faster in Crigler-Najjar syndrome type 1. Families should have a clear sick-day plan so early symptoms of dangerous bilirubin buildup are acted on quickly.
Taking in enough fluids helps support overall health and may reduce stress on the body during hot weather, stomach bugs, or feeding problems. In infants, fewer wet diapers or trouble feeding should be treated as urgent warning signs.
Can you prevent Crigler-najjar syndrome type 1?
No, Crigler-Najjar syndrome type 1 cannot be prevented in the usual sense, because it is a rare inherited condition that a baby is born with when both parents pass on the same changed gene. If this condition runs in your family, genetic counseling and family testing before pregnancy can help you understand the risk of passing it on, but they cannot guarantee prevention.
Transmission
Crigler-Najjar syndrome type 1 is not infectious, so it cannot spread from one person to another through touching, coughing, kissing, sex, food, or blood. Instead, the genetic transmission of Crigler-Najjar syndrome type 1 happens before birth, most often when a baby inherits one nonworking copy of the same gene from each parent.
Parents are usually healthy carriers, so many living with Crigler-Najjar syndrome type 1 are the first in their family to be diagnosed. This means Crigler-Najjar syndrome type 1 is not contagious at all; when both parents are carriers, each pregnancy has a 25% chance of being affected, and genetic counseling can help families understand how Crigler-Najjar syndrome type 1 is inherited.
When to test your genes
Consider genetic testing as soon as a newborn has severe, persistent unconjugated jaundice in the first days of life, especially if phototherapy is needed or there is a family history. Testing can confirm Crigler-Najjar syndrome type 1, guide urgent care, and help with future pregnancy planning for parents and relatives.
Diagnosis
Crigler-Najjar syndrome type 1 is usually suspected very early in life, often when a newborn has severe jaundice that does not improve in the usual way. Because this condition is rare, the diagnosis depends on a careful look at the pattern of symptoms along with specific lab and genetic tests. Getting a diagnosis is often a turning point toward answers and support. In the genetic diagnosis of Crigler-Najjar syndrome type 1, doctors focus on ruling out more common causes of high bilirubin and confirming the underlying gene change.
Doctors look for intense jaundice starting in the first days of life, often with very high unconjugated bilirubin levels. This pattern, especially in an otherwise structurally normal liver, raises strong concern for Crigler-Najjar syndrome type 1.
Blood tests measure total and direct bilirubin to show that the bilirubin is mainly unconjugated. Liver enzyme tests and other lab tests may help rule out common conditions such as liver inflammation, infection, or blood cell breakdown.
Doctors may check whether bilirubin levels improve with medicines that usually help in milder related conditions. In Crigler-Najjar syndrome type 1, there is typically little or no meaningful response, which helps distinguish it from type 2.
Genetic tests look for changes in the UGT1A1 gene, which is the usual cause of Crigler-Najjar syndrome type 1. Finding two disease-causing variants can confirm the diagnosis and help with family counseling.
How is Crigler-najjar syndrome type 1 diagnosed?
Doctors usually suspect Crigler-Najjar syndrome type 1 in a newborn with severe jaundice and blood tests showing a very high level of bilirubin, the yellow substance that builds up in the body. They also rule out more common causes of jaundice, such as blood type problems, infection, or liver disease, and type 1 is strongly suggested when the bilirubin stays extremely high and does not improve with phenobarbital, a medicine that can help in the milder form. A genetic test can then confirm the diagnosis by finding a change in the UGT1A1 gene.
Stages of Crigler-najjar syndrome type 1
Crigler-Najjar syndrome type 1 does not have defined progression stages. This is because it is a genetic condition present from birth, and the main problem is ongoing very high bilirubin levels rather than a step-by-step pattern of worsening over time. Identifying the cause is the starting point for the right care, and the diagnosis of Crigler-Najjar syndrome type 1 is usually based on severe jaundice starting in infancy, blood tests showing very high unconjugated bilirubin, and tests that rule out other liver problems. Genetic testing can confirm the diagnosis and help guide family counseling.
Outlook and prognosis
The outlook for people with Crigler-Najjar syndrome type 1 is serious because severe, lifelong unconjugated hyperbilirubinemia begins in infancy and can rapidly lead to bilirubin encephalopathy and kernicterus if not tightly managed. Without effective treatment, the condition carries a high risk of early neurologic injury and death, often in infancy or early childhood. Intensive daily phototherapy and careful monitoring can improve survival during childhood, but this treatment usually becomes less effective and more difficult to maintain with age. Liver transplantation is currently the only definitive therapy and can greatly improve long-term prognosis by correcting the underlying bilirubin conjugation defect. Even with treatment, some individuals may have permanent neurologic complications if bilirubin levels were not adequately controlled early in life. Overall mortality has improved with modern care, but untreated or poorly controlled disease remains life-threatening.
Long-term effects
For people living with Crigler-Najjar syndrome type 1, the main long-term concern is ongoing exposure of the brain and body to very high bilirubin levels, especially without consistent treatment. This can shape health from infancy onward, affecting movement, hearing, learning, and overall development. Long-term effects vary widely, but severe neurologic injury is the key reason early, lifelong care matters.
The most serious long-term effect is bilirubin damage to the brain, sometimes called kernicterus. This can lead to lasting problems with movement, muscle tone, coordination, and learning.
Many children with Crigler-Najjar syndrome type 1 may reach milestones later than expected if bilirubin has affected the nervous system. Over time, this can influence speech, school learning, and independent daily skills.
Some people develop involuntary movements, stiffness, balance trouble, or difficulty controlling posture. For many, this can mean walking is less steady or fine hand tasks are harder.
Damage related to high bilirubin can affect the hearing pathways in the brain and inner ear. Some may have permanent hearing loss that becomes clear in infancy or early childhood.
How is it to live with Crigler-najjar syndrome type 1?
Living with Crigler-Najjar syndrome type 1 usually means building daily life around treatment from the very start, especially many hours of phototherapy each day and close follow-up to keep bilirubin levels from rising high enough to injure the brain. For many living with this condition, that can mean disrupted sleep, limits on travel and spontaneity, frequent medical visits, and often planning for a liver transplant, which may offer the most durable long-term control. The impact reaches the whole family, because parents and other loved ones often take on intensive caregiving, monitor for warning signs, and organize home, school, and social life around a rare condition that demands constant attention.
Treatment and drugs
Crigler-Najjar syndrome type 1 needs ongoing treatment because the body cannot clear bilirubin properly, which can let this yellow pigment build up in the blood and brain. In daily life, treatment often centers on many hours of special blue-light therapy, called phototherapy, often done at home, especially in infancy and childhood. Doctors may also use medicines that help move bilirubin out of the body and may advise careful feeding plans to avoid fasting, since low calorie intake can make bilirubin levels rise. Not every treatment works the same way for every person, but for many living with Crigler-Najjar syndrome type 1, the only long-term treatment that can fully correct the problem is a liver transplant. Because this condition is rare and serious, care is usually guided by a specialist team that closely watches bilirubin levels and helps families respond quickly if early symptoms of high bilirubin appear.
Can you cure Crigler-najjar syndrome type 1?
Crigler-Najjar syndrome type 1 cannot be cured with medicine, but a liver transplant is the only well-established treatment that can provide a long-term cure by giving the body the liver function it is missing. Until then, treatment focuses on keeping the yellow waste substance from building up too high, usually with many hours of special light treatment each day and close medical care.
Non-drug treatment
Living with Crigler-Najjar syndrome type 1 usually means building daily life around keeping bilirubin levels as low as possible. For many, treatment begins not at the pharmacy, but with long hours of special blue-light therapy, close monitoring, and planning ahead for illness or missed treatments. In babies and children, this can mean sleeping under phototherapy lights at night and arranging family routines around equipment and clinic visits. Because the condition can cause severe jaundice from birth, non-drug care aims both to lower bilirubin now and to prevent bilirubin-related brain injury over time.
Intensive blue-light phototherapy is the main non-drug treatment for Crigler-Najjar syndrome type 1. It helps change bilirubin in the skin into forms the body can remove more easily. Many living with Crigler-Najjar syndrome type 1 need it for many hours each day, often overnight at home.
A liver transplant is the only established long-term treatment that can correct the underlying problem in Crigler-Najjar syndrome type 1. It can greatly reduce or eliminate the need for phototherapy, but it is major surgery and needs lifelong specialist follow-up.
If bilirubin rises to dangerous levels, especially in newborns or during illness, urgent hospital treatment may be needed. This can include exchange transfusion or other blood-clearing procedures to quickly lower bilirubin and reduce the risk of brain injury. Early symptoms of Crigler-Najjar syndrome type 1, such as deep jaundice in a newborn, need prompt medical attention.
Regular blood tests are used to track bilirubin levels and guide how much phototherapy is needed. Many children also need ongoing hearing, developmental, and neurologic checks, because high bilirubin can affect the brain even when daily care is in place.
Your genes may have an impact on how drugs work for you
In Crigler-Najjar syndrome type 1, the genetic change causes the liver pathway that normally helps clear bilirubin to be almost completely absent, so medicines that can help in milder forms usually do not work here. A well-known example is phenobarbital, which can lower bilirubin in some other people with severe jaundice but does not help in type 1 because the body cannot switch on enough of the missing liver activity. For many living with this condition, that is why treatment usually relies on light therapy and, in some cases, a liver transplant rather than expecting a medicine to fix the problem.
Pharmacological treatments
For many living with Crigler-Najjar syndrome type 1, medicines play only a limited role because the main problem is a near-complete lack of the liver activity needed to clear bilirubin. In day-to-day life, treatment usually depends more on intensive light therapy and often liver transplant planning than on drugs alone. Still, a few medicines may be used in selected situations to lower bilirubin for a time or to support urgent care, so understanding the treatment for Crigler-Najjar syndrome type 1 can help families know what to expect. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
Tin mesoporphyrin can reduce how much bilirubin the body makes, which may help bring levels down for a while. It is not a cure for Crigler-Najjar syndrome type 1 and is not routinely available in many places.
Phenobarbital is an important comparison drug because it often helps in type 2, but it usually does not work in Crigler-Najjar syndrome type 1. In practice, little or no response to phenobarbital supports the diagnosis of type 1 rather than serving as a useful long-term treatment.
Albumin given into a vein may be used during severe rises in bilirubin or around exchange transfusion to help bind bilirubin in the bloodstream. This is usually short-term hospital treatment, not an everyday medicine.
Drugs such as cholestyramine have been used to try to reduce bilirubin reabsorption from the gut. Benefit is often limited, so these medicines are considered add-on options rather than standard main treatment.
Genetic influences
For families facing severe jaundice in the first days of life, it can help to know that Crigler-Najjar syndrome type 1 has a clear inherited cause. This type happens when both copies of the UGT1A1 gene are not working, so the liver cannot clear bilirubin normally and levels can become dangerously high. A carrier means you hold the gene change but may not show symptoms, which is why parents are often healthy even though their child is affected. Crigler-Najjar syndrome type 1 follows an autosomal recessive pattern, so when both parents are carriers, each pregnancy has a 1 in 4 chance of the condition. Genetic testing for Crigler-Najjar syndrome type 1 can confirm the diagnosis and help relatives understand their own carrier risk.
Is Crigler-najjar syndrome type 1 genetic?
Genetics are central to Crigler-Najjar syndrome type 1. It is caused by harmful changes in the UGT1A1 gene, and the exact genetic variant can help confirm the diagnosis and guide family testing.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, often called genetic variants, are a usual part of human biology and are common in the general population. Most of these variants do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families living with Crigler-Najjar syndrome type 1, one of the biggest treatment questions is why standard jaundice medicines are often not enough. Not every difference in response is genetic, but in Crigler-Najjar syndrome type 1 the inherited change in the UGT1A1 gene is the main reason treatment choices are different. Because this gene is not working, the liver cannot change bilirubin into a form the body can clear.
That is why phenobarbital, a medicine that can help lower bilirubin in the milder type 2 form, usually does not work in type 1. Instead, treatment often depends on intensive phototherapy and, for many, liver transplant is the most effective long-term option, while gene-based treatments are still being studied. Doctors are also careful with other medicines, because some drugs can raise bilirubin or make it easier for bilirubin to move out of the bloodstream and into the brain. Understanding how genetics affect treatment for Crigler-Najjar syndrome type 1 helps doctors choose safer medicines and avoid treatments that are unlikely to help.
Interactions with other conditions
For many living with Crigler-Najjar syndrome type 1, other illnesses can quickly make day-to-day symptoms harder to manage, especially if they lead to dehydration, poor feeding, fever, or extra stress on the body. Infections and disorders that increase the breakdown of red blood cells can raise bilirubin levels further, which may deepen jaundice and increase the risk of bilirubin affecting the brain. A condition may exacerbate, or make worse, symptoms of another, and in Crigler-Najjar syndrome type 1 this matters because even short periods of illness can upset a careful treatment routine. Some may find that the early symptoms of worsening bilirubin, such as unusual sleepiness, trouble feeding, or changes in muscle tone, show up during another health problem rather than on their own. Doctors also watch closely if liver disease, severe illness, or problems affecting nutrition are present, since these can complicate overall care even though Crigler-Najjar syndrome type 1 itself is a genetic condition present from birth. Because of this, prompt treatment of common illnesses and close follow-up with a specialist team are an important part of staying safe.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Crigler-najjar syndrome type 1?
Several other conditions can cause the same kind of yellowing of the skin and eyes seen in Crigler-Najjar syndrome type 1, especially in newborns. The main ones doctors usually think about are common newborn jaundice, jaundice caused by a blood type mismatch between parent and baby, red blood cell conditions such as G6PD deficiency that make blood cells break down too fast, and liver or bile duct problems such as newborn hepatitis or biliary atresia. They may also compare it with the milder related condition, Crigler-Najjar syndrome type 2, because both can cause a buildup of bilirubin, the yellow substance behind jaundice.
History
Long before modern lab testing, babies with Crigler-Najjar syndrome type 1 were usually recognized by a striking pattern: deep jaundice that did not fade as expected after birth, along with serious illness caused by very high bilirubin levels in the blood. For families, this often meant a newborn who looked intensely yellow and needed urgent medical attention within days or weeks of life. At the time, doctors could describe what they were seeing, but they did not yet understand why it was happening.
In recent decades, awareness has grown from those early bedside observations into a much clearer medical picture. By the mid-20th century, physicians began separating this condition from other causes of newborn jaundice and recognized that some infants had an especially severe form, now known as Crigler-Najjar syndrome type 1. This mattered because the history of Crigler-Najjar syndrome type 1 is closely tied to one of its biggest day-to-day risks: without treatment, bilirubin can build up to dangerous levels and injure the brain.
As medical science evolved, better blood testing helped doctors measure bilirubin more accurately and follow how the condition changed over time. Researchers later identified a genetic cause, which confirmed that this was a distinct inherited disorder rather than a temporary liver problem. That shift improved diagnosis and also helped families understand why the jaundice was so severe and why it returned unless treated.
Treatment history has also shaped the outlook for people living with Crigler-Najjar syndrome type 1. In earlier eras, options were limited, and many infants did not survive. Over time, intensive light therapy, close monitoring, and eventually liver transplantation changed care in a major way, giving many children a far better chance of long-term survival. Knowing this history helps explain why early symptoms of Crigler-Najjar syndrome type 1 are taken so seriously today and why specialist care from the start is so important.